Net profit at Ganga Pharmaceuticals decreased by Rs.0.48 lacs in HY ended 31.3.2020 as compared to a year ago period.

Company : GCM Commodity & Derivatives Ltd

Ganga Pharmaceuticals published the audited standalone financial results of the company for the annual and half year ending on 31st March, 2020 marking a rise in revenue margins.

Following are the HY2 financials at Ganga Pharmaceuticals in FY2019-20:

- The revenue stood at Rs.1.78 crore as compared to Rs.1.67 crore in corresponding period of previous year

- Net profit was Rs.3.36 lacs for the half year ended 31.03.2020 as against Rs.3.84 lacs in previous year same period.

- Earnings per share for the current half year was Rs.0.42 as against Rs.0.09 in previous year corresponding period.

By the end of financial year 2019-20, Ganga Pharmaceuticals achieved net PAT of Rs.18.88 lacs whereas previous year it was Rs.18.71 lacs.

Revenue of the company reached Rs.3.24 crore against Rs.3.50 crore a year ago.

Recent Stories